Tenet Healthcare's stock has fallen 30% from recent highs, now trading at a compelling valuation of 10 times adjusted earnings. The company reported 2025 adjusted earnings of $17 per share, surpassing previous guidance, and expects stable earnings and strong buybacks in 2026. Revenue growth is driven by higher pricing despite flat volumes and margin pressure, maintaining overall business stability. Despite challenges in the sector, Tenet's low debt and attractive earnings yield make it a promising investment opportunity.
Tenet Healthcare Corporation's stock has fallen 22.7% recently, but it remains a compelling Buy due to strong financial performance and a valuation discount compared to peers. The Ambulatory Care segment showed resilience with revenue rising from $1....
Last week, large-cap stocks in sectors like technology, electric vehicles, data centers, and healthcare experienced declines due to weak earnings guidance, regulatory worries, rising bond yields, and increased competition. Notable losers included Int...
AllianceBernstein Global High Income Fund, Inc. released its April 30, 2026 portfolio update, reporting total net assets of $980.33 million and an average bond coupon of 7.08%. The fund holds 1,228 investments, primarily in U.S. dollar-denominated bo...
